Telma LN Maximum Daily Dose
The maximum daily dose of Telma-LN (telmisartan/cilnidipine combination) is telmisartan 80 mg plus cilnidipine 10 mg, taken once daily.
Dosing Based on Individual Components
Since Telma-LN is a fixed-dose combination of telmisartan and cilnidipine, the maximum dose is determined by the upper limits of each component:
Telmisartan Component
- Maximum dose: 80 mg once daily 1, 2, 3
- This represents the highest approved dose for telmisartan across major hypertension guidelines
- The ACC/AHA guidelines consistently list telmisartan's usual dose range as 20-80 mg daily with once-daily frequency
Cilnidipine Component
- Typical dose: 10 mg once daily 4, 5, 6
- Recent clinical trials in Indian populations have used cilnidipine 10 mg as the standard dose when combined with telmisartan 40 mg
- While cilnidipine can be used at higher doses as monotherapy, the combination formulation typically contains 10 mg
Clinical Context for Combination Therapy
The telmisartan 40 mg/cilnidipine 10 mg combination is the most commonly studied and prescribed formulation 4, 5, 6. This lower-dose combination effectively reduces blood pressure while minimizing adverse effects. If blood pressure control is inadequate at this dose, titration to telmisartan 80 mg/cilnidipine 10 mg would represent the maximum combination dose.
Evidence for Combination Efficacy
Recent studies demonstrate that telmisartan-cilnidipine combinations:
- Significantly reduce both office and ambulatory blood pressure 4
- Provide renoprotective benefits in patients with chronic kidney disease 5
- Show comparable safety profiles with fewer peripheral edema events compared to amlodipine-based combinations 5, 7
Important Caveats
- Dose titration should occur gradually over 2-4 weeks to assess tolerance and response
- Monitor for hypotension, especially in volume-depleted patients or those on multiple antihypertensives
- Check renal function and potassium levels periodically, as telmisartan can cause hyperkalemia, particularly in patients with chronic kidney disease 1, 2
- Avoid in pregnancy - both ARBs and calcium channel blockers have specific pregnancy considerations 8
The combination should be taken once daily, preferably at the same time each day, and can be taken with or without food.